HuGE Literature Finder
Records
1
-
4
Genetic variants of DOCK2, EPHB1 and VAV2 in the natural killer cell-related pathway are associated with non-small cell lung cancer survival. American journal of cancer research 2021 11 (5): 2264-2277. Du Hailei, Liu Lihua, Liu Hongliang, Luo Sheng, Patz Edward F, Glass Carolyn, Su Li, Du Mulong, Christiani David C, Wei Qing |
PDL1 high expression without TP53, KEAP1 and EPHA5 mutations could better predict survival for patients with NSCLC receiving atezolizumab. Lung cancer (Amsterdam, Netherlands) 2020 Nov . Wang Haiyong, Shan Qinge, Guo Jun, Han Xiao, Zhao Chenglong, Li Huijuan, Wang Zheh |
Driver Gene and Novel Mutations in Asbestos-Exposed Lung Adenocarcinoma and Malignant Mesothelioma Detected by Exome Sequencing. Lung 2015 Oct . Mäki-Nevala Satu, Sarhadi Virinder Kaur, Knuuttila Aija, Scheinin Ilari, Ellonen Pekka, Lagström Sonja, Rönty Mikko, Kettunen Eeva, Husgafvel-Pursiainen Kirsti, Wolff Henrik, Knuutila Saka |
Mutated ephrin receptor genes in non-small cell lung carcinoma and their occurrence with driver mutations-targeted resequencing study on formalin-fixed, paraffin-embedded tumor material of 81 patients. Genes, chromosomes & cancer 2013 Dec 52 (12): 1141-9. Mäki-Nevala Satu, Kaur Sarhadi Virinder, Tuononen Katja, Lagström Sonja, Ellonen Pekka, Rönty Mikko, Wirtanen Aino, Knuuttila Aija, Knuutila Saka |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 26, 2022
- Content source: